Presentation and Q&A session scheduled for
post-market on Monday, May 16,
2022
BOSTON, May 9, 2022
/PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal
platform for cell programming, announced today that it plans to
host a presentation and Q&A session reviewing business
performance for the first quarter ended March 31, 2022, on Monday,
May 16, 2022, beginning at 4:30 p.m.
ET.
The presentation details and webcast link will be available on
Ginkgo's investor relations website at
https://investors.ginkgobioworks.com, and a replay will be made
available.
To ask a question ahead of the presentation, please submit them
to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an
e-mail to investors@ginkgobioworks.com.
About Ginkgo Bioworks
Ginkgo is building a platform to
enable customers to program cells as easily as we can program
computers. The company's platform is enabling biotechnology
applications across diverse markets, from food and agriculture to
industrial chemicals to pharmaceuticals. Ginkgo has also actively
supported a number of COVID-19 response efforts, including K-12
pooled testing, vaccine manufacturing optimization and therapeutics
discovery. For more information, visit
https://www.ginkgobioworks.com/.
Ginkgo Bioworks Contacts:
INVESTOR
CONTACT:
investors@ginkgobioworks.com
MEDIA CONTACT:
press@ginkgobioworks.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-first-quarter-2022-results-presentation-301542271.html
SOURCE Ginkgo Bioworks